Core C is a new core in our submission that offers much needed expertise in pathology and virology to? Projects 2 and 3 and to Core B. The services, expertise and reagents provided by this core helps Projects 2? and 3 and Core B to address criticisms and concerns that were raised by the review panel. Moreover, this? core provides some key services and reagents originally provided by former project 2 that has been deleted? in this resubmission. This core will 1). provide diagnostic pathology for the identification of hamster, mouse? and human malignant mesotheliomas (MM) and derived cell lines; 2). provide virology expertise and? reagents to Projects 2 and 3; 3). Characterize primary human mesothelial cell cultures and obtain primary? hamster mesothelial cell cultures; 4). provide human cell lines transformed by SV40, SV40 small tag mutants? and asbestos - alone or in combination; 5). provide hamster MM and derived cell lines induced by crocidolite? asbestos, SV40, SV40 small tag mutant plus crocidolite; 6). produce and provide similar in vitro and vivo? models using chrysotile asbestos; 7). using immunohistochemistry, in situ hibridization and laser capture? microdisection followed by Real Time and RT - PCR analyze gene pathways studied in Project 2 and 3 in? animal and human MM tumors induced by SV40 alone, SV40 small tag mutant plus crocidolite or chrysotile,? or by crocidolite or chrysotile alone; 8). provide independent SV40 testing of human MM biopsies using? immunoprecipitation, Western blotting and immunohistochemistry.
Showing the most recent 10 out of 52 publications
